|
 |
|
|
|
|
READERSHIP & CIRCULATION
|
|
|
JOB
TITLE
Heads of IT/Data Management-520
Corporate Heads -415
Compliance -410
Regulatory Affairs -410
Biostatistics and Analysis -625
CEOs-840
Lab Analysis -630
GCP Auditing -605
QA/QC -525
Clinical Trials -1255
Clinical Research -1045
Clinical trial management -946
R&D Project management –1260
Marketing Direction -1050 |
|
|
|
|
|
|
|
|
|
GEOGRAPHICAL DISTRIBUTION
Austria -105
Baltic States -210
Central America -525
Central Europe -1050
China -840
Finland -210
France and Germany -1470
India -315
Italy -210
Japan -105
Latin America -105
Scandinavia -420
South Africa -210
Spain -456
UK and Ireland -1050
US and Canada -3255 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ADVERTISING RATES
SIZE RATE
|
|
|
|
|
|
|
|
|
|
WEBSITE FACILITIES
|
|
A4
|
|
|
|
|
|
|
|
£2,200
|
| HALF-PAGE |
|
|
|
|
|
|
|
£1,375 |
| INSIDE FRONT COVER |
|
|
|
|
|
|
|
£3,500
|
| OUTSIDE BACK COVER |
|
|
|
|
|
|
|
£3,700
|
| CONTENTS |
|
|
|
|
|
|
|
£2,500
|
| DOUBLE PAGE SPREAD |
|
|
|
|
|
|
|
£4,000
|
| INSIDE FRONT COVER DPS |
|
|
|
|
|
|
|
£5,200
|
| INSIDE BACK COVER |
|
|
|
|
|
|
|
£3,000
|
|
|
|
|
|
|
|
|
|
|
1) Hyperlink from a relevant section of our website to client website
2) Banner and/or logo on our website (see below for banner specifications)
3) Client news page – to use for press releases during the duration of advertising.
4) Corporate profile up to 350 words
BANNER SPECIFICATIONS
GIF or JPEG (if static) or SWF (flash), 468 X 60 pix (centre or top) or 200 X 180 (right side)
All the above will be in place for as long as advertising runs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MECHANICAL SPECIFICATIONS REPROGRAPHIC |
|
|
MECHANICAL DETAILS (IN MM) |
|
 |
Type Size
|
Trim Size
|
Bleed Size
|
|
Double Page Spread |
273 x 396
|
297 x 420
|
303 x 426
|
|
One Page |
273 x 186
|
297 x 210
|
303 x 213
|
|
1/2 page (horizontal) |
135 x 186
|
148 x 210
|
151 x 213
|
|
1/2 page (vertical) |
273 x 92
|
297 x 105
|
303 x 108
|
|
1/4 page |
135 x 92
|
N/A
|
N/A
|
|
Client designed adverts should be supplied in one of the following ways:
QuarkXpress6 (not Quark Passport), with relevant high resolution graphics and fonts also supplied.
Adobe Illustrator CS2. Images and graphics must be embedded. Fonts should be suppliedif they are not embedded/converted to outline.
Adobe Acrobat PDF. Advert PDFs must be supplied optimised for high quality printing. All colours (inc. pictures) must be CMYK, no RGB or Pantone. They must include high resolution graphics (300dpi) and embedded fonts. Bleed adverts must include registration markings and bleed. We are unable to make amendments to PDF files.
How to supply files
Electronic files can be emailed to us. Larger files (above 10Mb) should be supplied to us on CD
Note All print adverts should be supplied with a colourcopy of the advert. PDFs are supplied entirely at the client’s own risk and the publisher accepts no responsibility for any errors in printing. Powerpoint, CorelDraw and Microsoft Word are not acceptable. |
|
|
 |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
Biomedical Systems Names New Managing Director For European Headquarters
St. Louis, MO - Biomedical Systems, a global provider of centralized diagnostic services for
clinical trials, announced that Geert Dewulf, MD has been named the Managing Director,
European Operations. Dr. Dewulf will assume the top post in the company's European
Headquarters in Brussels, Belgium from Rita Jacobs, who will be retiring from that post after
27 years with the organization. Dr. Dewulf came to Biomedical Systems from Agfa Healthcare
where he served as Managing Director for Germany, Austria and Switzerland.
More info >> |
|
|
